Omicron Biochemicals, Inc.中国区代理-上海维亦特生物

Omicron Biochemicals, Inc.中国区代理-上海维亦特生物

Omicron Biochemicals, Inc. develops new and improved methods to introduce stable isotopes, primarily 13C, 2H, 15N and 18O, into biologically-important compounds. We specialize in the synthesis of labeled carbohydrates, nucleosides, and their derivatives, but will undertake the synthesis of other classes of compounds on a custom basis. Our particular strengths lie in the preparation of site-specifically labeled compounds, but we are also capable of producing uniformly labeled products.

The approaches used in synthesis include chemical, chemi-enzymatic, enzymatic and biological methods. We also collaborate with other laboratories as needed to develop new products or distribute our products.

We take pride in providing quality stable isotopes in support of a wide range of scientific research programs worldwide. Our research activities frequently result in publication in peer-reviewed scientific journals, either independently or in collaboration with other research groups. We are a flexible research and development company, with both activities receiving equal weight and attention.

Omicron主要提供2H,13C,15N,18O标记化合物，专注于标记碳水化合物、核苷及其衍生物的合成。2021年3月，Omicron生物化学股份有限公司庆祝了其开业39周年。尽管Omicron已经取得了显著的成就，但Omicron仍然忠于其1982年确立的企业使命：以有竞争力的价格和及时的方式向全球客户提供高质量、稳定的同位素标记碳水化合物、核苷及其衍生物，提供卓越的个性化客户服务，并为员工的专业成长提供持续的机会。

Omicron专注于制备未标记和稳定同位素标记的低聚糖，包括高甘露糖N-聚糖和母乳低聚糖（HMOs）。母乳低聚糖（HMOs）作为对新生儿有益的膳食补充剂，它越来越受到关注。Omicron可大规模制备母乳低聚糖（HMOs），1g-100g均可提供。